Sarcoidosis

4,101 views

Published on

Published in: Technology, Health & Medicine
1 Comment
10 Likes
Statistics
Notes
  • I am very interested in this subject. I have two comments/questions:
    1. You did not include material on cardiac sarcoid....it would be great to have that covered as well
    2. Are you aware of any statistics on the sarcoid frequency by organ for those who have been diagnosed with sarcoid. For example, if one had biopsy diagnosed pulmonary sarcoid what is the probability of also getting cardiac or CNS sarcoid as well?
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total views
4,101
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
294
Comments
1
Likes
10
Embeds 0
No embeds

No notes for slide
  • Asteroid bodies are stellate inclusions with numerous rays radiating from a central core that are present in the cytoplasm of giant cells. . They may be be seen in sarcoidosis and other granulomatous disorders. They are most frequently encountered in the giant cells of foreign body granulomas
  • Sarcoidosis

    1. 1. SARCOIDOSIS Dr.Md.Mizanur Rahman Chowdhury
    2. 2. SARCOIDOSIS Definition :Sarcoidosis is a multisystem disorder of unknown etiology characterized by non caseating granuloma which affects mainly lung but can also any other organs .
    3. 3. EPIDEMIOLOGY It occurs mainly in 3rd or 4th decade of life  More predominant in women with an incidence of 6.3 vs 5.9 cases per 100,000 person-years. Lifetime risk for US whites is 0.85 percent compared with 2.4 percent in US blacks. More prevalent in Swedes, Danes, and US blacks.
    4. 4. EPIDEMIOLOGY Annual incidence in the U.S. is 10/100,000 among whites and 36/100,000 among African Americans. Most commonly seen in the mid-Atlantic and Southern Atlantic states but rare in the Southwest. Affects siblings of first- or second- degree relatives in 15% of patients with sarcoidosis. Familial cases described in 17% of African Americans, but only 6% of whites.
    5. 5. ETIOLOGY AND PATHOGENESIS Etiology of sarcoidosis is remain unknown, but several lines of evidence suggest that it is a disease of disordered immune regulation in genetically predispose individual. Immunological Factor There are several immunological abnormalities in the granuloma of sarcoidosis that suggest the development of cell mediated response to an unidentified antigen. These process are driven by CD4+T Cell.
    6. 6. ETIOLOGY AND PATHOGENESIS Intra-alveolar and interstitial accumulation of CD4+T cell ,resulting CD4/CD8 T cell ratio ranging from 5:1 to 15:1.There is oligoclonal expansion of T-cell subsets as determined by analysis of T cell receptor rearrangement, suggesting an antigen driven proliferation. Increase levels of T-cell derived TH 1 cytokines such as IL-2 and IFN-у resulting in T-cell expansion and macrophage activation respectively.
    7. 7. ETIOLOGY AND PATHOGENESIS Increase levels of cytokines in the local envirment (IL-8,Macrophage inflammatory protein 1 α ) that favour recruitment of additional T cell and Macrophage and contribution to the formation of granulomas. TNF in particular release of high levels by activated alveolar macrophage and the TNF concentration in the broncho alveolar fluid is a disease activity.
    8. 8. T cells, Macrophages Chemoattractants Growth Factors Cellular proliferation Granuloma Fibrosis
    9. 9. PATHOGENESIS
    10. 10. PATHOGENESIS
    11. 11. PATHOGENESOS
    12. 12. PATHOGENESIS
    13. 13. PATHOGENESIS
    14. 14. ETIOLOGY AND PATHOGENESIS Genetic Factor Evidence of genetic influences are the familial and racial clustering of cases and the association with certain HLA genotypes (eg:HLA-A1and HLA-B8)
    15. 15. ETIOLOGY AND PATHOGENESIS Envirment factor These are possibly the most tenuous of all the associations in the pathogenesis of sarcoidosis. As with many other diseases of unknown etiology, suspicion fall on microbes. Indeed several putative microbes have been proposed as the inciting agent for sarcoidosis (eg- mycobacteria, propionobacterium acnes, Rickettsia species)
    16. 16. MORPHOLOGY Histologically all involved tissues show the classic well formed noncaseating granuloma, each composed of an aggregates of tightly clustered epithelioid cell, often with langhans or foreign body giant cell, central necrosis is unusual with chronicity the granulomas may become enclosed within fibrous rimes or may be eventually be replaced by hyaline fibrous scars.
    17. 17. MORPHOLOGY laminated concentration composed of calcium and proteins known as schaumann bodies and stellate inclusion as asteroid bodies enclosed with in giant cells are formed in approximately 60% of granulomas.though characteristic these microscopic features are not pathognomic of sarcoidosis because asteroid and schaumann bodies may be encounteered in other granulomatous disease
    18. 18. LANGHANS' GIANT CELL LANGHANS' GIANT CELL IN CENTER OF GRANULOMA IS SURROUNDED BY EPITHELIOID CELLS
    19. 19. ADVANCED COLLAGENOUS FIBROSIS ELONGATED FIBROBLASTS (FB) WITH EXTENSIVE COLLAGENOUS TISSUE (C). GIANT CELLS (ARROWS)
    20. 20. CYTOPLASMIC INCLUSION BODY SCHAUMANN BODY (ARROW) IS COMMON IN SARCOIDOSIS BUT IS NONSPECIFIC.
    21. 21. CYTOPLASMIC INCLUSION BODY SCHAUMANN BODY (ARROW)
    22. 22. ASTEROID BODIES
    23. 23. ASTEROID BODIES
    24. 24. ASTEROID BODIES
    25. 25. SYSTEMS AFFECTED BY SARCOIDOSIS Systems Percentage Pulmonary 90% Lymph nodes 70% Hepatic 50-80% Cardiac 30% Cuteneous 25% Ocular 20% Spleen 18% Bones 14% Neurogenic 5%
    26. 26. PULM0NARY SARCOIDOSIS
    27. 27. PULMONARY SARCOIDOSIS First side of involvement Begain with alveolitis involving small bronchi and small blood vessels Alvveolitis either clear up spontaneously or lead to granuloma or fibrosis
    28. 28. PULMONARY SARCOIDOSIS Microscopically. There is usually no demonstrable alteration , although in advanced cases the coalescence of granuloma produce small nodule that are palpable or visible as 1 to 2cm noncaseating, noncavitary consolidation.
    29. 29. PULMONARY SARCOIDOSIS Histologically. The lesion are distributed primarily along the lymphatic's, around the bronchi and blood vessels, although alveolar lesion are also seen in relative frequency. The granulomas in the bronchial sub mucosa account for the high diagnostic yield of bronchoscopic biopsy. There seems to be a strong tendency for lesion to heals in the lungs, so varying stages of fibrosis, hyalinization are not found
    30. 30. NONCASEATING GRANULOMA IN LUNG IS THE CHARACTERISTIC LESION OF SARCOIDOSIS.
    31. 31. CASEOUS NECROSIS CELLULAR DESTRUCTION IN TB GRANULOMA APPEARS AS CLUMPED DEBRIS (ARROWS). THIS NECROSIS DOES NOT OCCUR IN SARCOIDOSIS.
    32. 32. M. TUBERCULOSIS BACILLI CASEOUS NECROSIS IS MOST COMMON IN TB, BUT GRAM NEGATIVE, ACID FAST BACILLI MUST BE IDENTIFIED TO MAKE THE DIAGNOSIS.
    33. 33. SUBPLEURAL GRANULOMA IN LUNG
    34. 34. STAGE I THORACIC LYMPHADNOPATY. NORMAL LUNG PARENCHYMA. (50%)
    35. 35. STAGE II HILAR AND MEDIASTINAL LYMPHADNOPATY. ABNORMAL LUNG PARENCHYMA. ( 30% )
    36. 36. STAGE III ABNORMAL LUNG PARENCHYMA. NO LYMPHADNOPATY. ( 15% )
    37. 37. STAGE IV EXTENSIVE PULMONARY FIBROSIS IS TYPICALLY WORST IN THE UPPER LOBES.
    38. 38. STAGE IV BROAD BANDS OF FIBROSIS IN THE UPPER LOBES
    39. 39. MILIARY SARCOIDOSIS CT SHOWS WELL DEFINED LUNG NODULES LESS THAN 5MM IN DIAMETER. THIS PATTERN IS RARE
    40. 40. ALVEOLAR SARCOIDOSIS MULTIPLE LUNG MASSES ARE AN UNUSUAL FORM OF SARCOIDOSIS, RESEMBLES LUNG METASTASES.
    41. 41. ALVEOLAR SARCOIDOSIS COMPUTED TOMOGRAPHY SHOWS A MASS WHICH HAS AIR CONTAINING BRONCHI (ARROWS) WITHIN IT.
    42. 42. CAVITARY SARCOIDOSIS RARE PATTERN OF MULTIPLE CAVITARY SARCOID LUNG LESIONS. NOTE LYMPHADNOPATY.
    43. 43. RETICULONODULAR PATTERN COMMON APPEARANCE OF SARCOIDOSIS INVOLVING THE LUNG PARENCHYMA.
    44. 44. RETICULONODULAR PATTERN CLOSEUP WELL DEFINED LINEAR AND NODULAR DENSITIES CHARACTERISTIC OF LUNG INTERSTITIAL DISEASE.
    45. 45. ACINAR PATTERN POORLY DEFINED NODULAR OPACITIES ARE THE SIZE OF PULMONARY ACINI (6MM).
    46. 46. PNEUMONIC APPEARANCE CONFLUENT ACINAR OPACITIES LOOK SIMILAR TO PNEUMONIC CONSOLIDATION.
    47. 47. NODULAR PATTERN SMALL 5MM NODULES ARE SUBPLEURAL, ALONG FISSURES AND BRONCHOVASCULAR BUNDLES. GIVE THE VESSELS (ARROW) AND FISSURES A BEADED APPEARANCE.
    48. 48. LYMPH NODES WITH RIM (EGGSHELL) CALCIFICATION (ARROW) ARE RARE IN SARCOIDOSIS BUT COMMON IN SILICOSIS.
    49. 49. MOST COMMON PATTERN BILATERAL SYMMETRIC HILAR AND RIGHT PARATRACHEAL MEDIASTINAL ADENOPATHY.
    50. 50. STAGE IV PERMANENT LUNG FIBROSIS. (20%)
    51. 51. DIFFERENTIAL DIAGNOSIS OF NONCASEATING GRANULOMAS TB Fungal infections Lymphoma Epithelioid tumors of the breast Lung cancer
    52. 52. DIFFERENTIAL DIAGNOSIS OF BHL Granulomatous infections TB Histoplasmosis Coccidiomycosis Autoimmune disorders Malignancy (Lymphoma)
    53. 53. CLINICAL PRESENTATION Most patients have the pulmonary manifestations, most commonly presenting with incidental findings on CXR. Interstitial disease Symptoms include dry cough, dyspnea, and chest discomfort Unpredictable course
    54. 54. PROGNOSIS OF PULMONARY SARCOIDOSIS Prognosis of pulmonary sarcoidosis 3/4 1/3 1/5 Complete resolution of hilar lymphadenopathy Complete resolution of parenchymal disease Irreversible pulmonary fibrosis
    55. 55. LYMPH NODES sarcoidosis
    56. 56. SARCOIDOSIS OF LYMPH NODES Lymphadnopathy Lymph nodes are involved in almost all cases particularly the hilar and medistinal nodes, but any other nodes may be involved .nodes are characteristically enlarge discrete and sometimes calcified Tonsil may affected in about quarter to one third of the cases
    57. 57. LYMPHADENOPATHY Typical 1.Bilateral hilar & right paratracheal LN, 2.Middle mediastinal LN occur in 50% of cases. 3.Left paratracheal, aorto-pulmonary & subcarinal LN. 1-2-3 sign present in 95% of cases. This is called Garland triad
    58. 58. LYMPHADENOPATHY Atypical 1.Unilateral hilar LN. 2.Anterior or posterior mediastinal LN. 3.LN calcification (amorphus, punctate, popcorn or eggshell calcification).
    59. 59. LYMPHADENOPATHY Sarcoidosis Typical Atypical Garland triad Unilateral hilar LN Anterior or posterior mediastinal LN LN calcification
    60. 60. LYMPHADENOPATHY
    61. 61. LYMPHADENOPATHY
    62. 62. LYMPHADENOPATHY
    63. 63. LYMPHADENOPATHY
    64. 64. ENLARGED BILATERAL HILAR, RIGHT PARATRACHEAL (ARROW), AND AORTOPULMONARY WINDOW (ARROWHEAD) NODES.
    65. 65. CALCIFIED LYMPH NODES LATE MANIFESTATION IN 5% OF PATIENTS.
    66. 66. PARACARDIAC LYMPH NODE
    67. 67. ABDOMINAL LYMPHADENOPATHY MULTIPLE ENLARGED PARAAORTIC, PARACAVAL, AND PORTA HEPATIS LYMPH NODES (ARROWS).
    68. 68. CUTENEOUS sarcoidosis
    69. 69. SKIN  33% have skin lesions  Cutaneous anergy is common.  LOFGREN'S SYNDROME; acute triad of erythema nodosum, joint pains, and bilateral hilar adenopathy
    70. 70. NAKED GRANULOMA YOUNG GRANULOMAS (ARROWS) IN THE SKIN WITH NO SURROUNDING RIM OF MONONUCLEAR CELLS.
    71. 71. ERYTHEMA NODOSUM THESE REDDISH RAISED LESIONS
    72. 72. ERYTHEMA NODOSUM
    73. 73. ERYTHEMA NODOSUM
    74. 74. SKIN  Lupus pernio- indurated blue purple swollen shiny lesions on nose, cheeks, lips, ears and fingers.  Papules, nodules, and plaques  Psoriatic like lesions  Lesions in scars and tattoos
    75. 75. LUPUS PERNIO FACIAL LESIONS ARE MOST COMMON, BUT THE EXTREMITIES AND BUTTOCKS CAN BE INVOLVED.
    76. 76. LUPUS PERNIO INDURATED AND VIOLACEOUS RANGE FROM A FEW SMALL LESIONS TO LARGE LESIONS
    77. 77. LUPUS PERNIO
    78. 78. RAISED PLAQUES THESE RAISED PLAQUES ARE THE RESULT OF COALESCENCE OF NODULES.
    79. 79. PSORIASIS LIKE LESIONS THESE SMALL WHITE LESIONS CLOSELY RESEMBLE PSORIASIS.
    80. 80. SARCOID SKIN LESION
    81. 81. OCCULAR sarcoidosis
    82. 82. EYES 25% have eye lesions Blurred vision, pain, photophobia and dry eyes Chronic uveitis leads to glaucoma, cataracts and blindness Keratoconjunctivitis sicca Papilledema
    83. 83. CONJUNCTIVITIS
    84. 84. PAPILLEDEMA OFTEN ASSOCIATED WITH 7TH NERVE FACIAL PALSY.
    85. 85. SARCOID CHOREORETINITIS
    86. 86. SARCOIDUVEITIS Hypopion posterior synechiae :Iris deformity cataract
    87. 87. LIVER sarcoidosis
    88. 88. LIVER 33% have hepatomegaly or biochemical evidence of disease Symptoms usually absent Cholestasis, fibrosis, cirrhosis, portal hypertension, and the Budd-Chiari syndrome have been seen
    89. 89. SPLEEN & LIVER GRANULOMAS THE SMALL LOW ATTENUATION LESIONS IN THE LIVER AND SPLEEN IN SARCOIDOSIS.
    90. 90. EARLY COLLAGEN FORMATION EXTRACELLULAR COLLAGEN (C) IS BEING PRODUCED BY FIBROBLASTS
    91. 91. MUSCULOSKELETAL SARCOIDOSIS
    92. 92. MUSCULOSKELETAL  Acute polyarthritis with fever is common  Arthritis is self limited  Chronic destructive bone disease with deformity is rare  Polymyositis and chronic myopathy  Muscle disease is rare
    93. 93. PUNCHED OUT LYTIC LESIONS FOCAL OSTEOLYTIC LESIONS IN THE FINGERS ARE MOST COMMON ABNORMALITY.
    94. 94. LACY TRABECULAR PATTERN OSTEOLYSIS HAS LEFT A LACY TRABECULAR PATTERN IN THIS PHALANX (ARROW)
    95. 95. SCLEROTIC LESION RARE AND OFTEN IN THE AXIAL SKELETON.
    96. 96. NASAL BONE LESION NASAL SARCOIDOSIS CAN LEAD TO OSTEOLYSIS OF THE NASAL BONE (ARROWS).
    97. 97. NERVOUS SYSTEM SARCOIDOSIS
    98. 98. NERVOUS SYSTEM Cranial nerves, and peripheral nerves can be involved 7th nerve facial palsy is most common Acute, transient, and can be unilateral or bilateral HEREFORDT'S SYNDROME; facial palsy accompanied by fever, uveitis, and enlargement of the parotid gland
    99. 99. T1-W POST GADOLINIUM MR IMAGE POST CONTRAST IMAGE OF HIGH SIGNAL INTENSITY TEMPORAL LOBE SARCOID LESION (ARROW)
    100. 100. T2-W MR IMAGE HIGH SIGNAL INTENSITY EDEMA SURROUNDING BIOPSY PROVEN SARCOID LESION.
    101. 101. NERVOUS SYSTEM  Optic nerve dysfunction  Papilledema  Palate dysfunction  Hearing abnormalities  Paresthesias  Meningeal granulomas  Encephalopathy
    102. 102. KIDNEY SARCOIDOSIS
    103. 103. KIDNEY Granulomatous interstitial nephritis produces renal failure Develops over a period of weeks to months Rapid response to steroid therapy Kidney stones (nephrolithiasis) and nephrocalcinosis are very unusual secondary to hypercalcemia and hypercalciuria
    104. 104. NEPHROCALCINOSIS THERE ARE MULTIPLE CALCIFICATIONS OF THE KIDNEYS. ENLARGED RETROPERITONEAL LYMPH NODES (ARROWS)
    105. 105. KIDNEY Increased calcium absorption in the gut Related to high levels of circulating 1,25-dihydroxy vitamin D produced by mononuclear phagocytes in granulomas
    106. 106. GASTRIC SARCOID GRANULOMA INVOLVES THE GASTRIC ANTRUM LEADING TO IRREGULAR NONSPECIFIC NARROWING.
    107. 107. COLONIC SARCOID IRREGULAR NARROWING OF THE RECTOSIGMOID HAS THE APPEARANCE OF INFLAMMATORY DISEASE OR MALIGNANCY.
    108. 108. LAB ABNORMALITIES  Lymphocytopenia  Mild eosinphilia  Increased E.S.R  Hyperglobulenemia
    109. 109. LAB ABNORMALITIES Elevated level of angiotensin converting enzyme Gallium 67 lung scan showing a pattern of diffused uptake. Bronchiole alveolar lavage shows increased lymphocytes
    110. 110. LUNG FUNCTION TEST Lung function abnormalities for interstitial lung disease with decreased lung volumes and diffusing capacities
    111. 111. RADIOGRAPHY  “Egg shell” calcification of hilar nodes Plural effusions Cavitations Atelectasis Pulmonary hypertension Pneumothorax Cardiomegaly
    112. 112. DIAGNOSIS Identify noncaseating granulomas Variety of infections Transbronchial biopsies positive in 65- 95%, even if no lung parenchymal abnormalities imaged. Tissue from mediastinoscopy positive in 95% Scalene node biopsy positive in 80%
    113. 113. DIAGNOSIS Difficult to differentiate from chronic infections, fungal diseases, T.B. and lymphoma. Based on combined clinical, radiologic and histologic findings. Laboratory tests seldom important Asymptomatic
    114. 114. ADENOPATHY AT TIME OF DIAGNOSIS MARKED ENLARGED HILAR AND MEDIASTINAL LYMPH NODES.
    115. 115. ADENOPATHY DECREASED 2 YRS LATER LYMPH NODES ARE SMALLER AND THERE IS PARENCHYMAL LUNG DISEASE.
    116. 116. DIAGNOSIS KVEIM TEST Involves injecting standardized preparation of sarcoid tissue material into the skin. Unique lump formed at the point of injection is considered positive for sarcoidosis.
    117. 117. THE KVEIM-SILTZBACH TEST The Kveim-Siltzbach skin test is based upon studies conducted by Dr. Morten Ansgar Kveim, a Norwegian dermatologist, and published in 1941. The test was later studied extensively and popularized by Dr. Louis Siltzbach at the Mt. Sinai Medical Center in New York City. It is the only test that, if positive, is considered to be diagnostic of sarcoidosis. The test material, a suspension of granuloma-containing spleen, lymph node, or other tissue from a confirmed case of sarcoidosis, is injected intradermally. A positive test is characterized by the formation of a papule at the site of injection within 4-6 weeks which, on microscopic examination, exhibits non-necrotizing granulomas and the absence of foreign material.
    118. 118. THE KVEIM-SILTZBACH TEST The Kveim test has been reported to be positive in a mean of 78% of patients with sarcoidosis worldwide (range 54%- 92%). A satisfactory test suspension will identify at least 60% of patients with active sarcoidosis and will yield no more than 1% of false positive results in individuals without sarcoidosis. A positive Kveim test assures a diagnosis of sarcoidosis in 97%-98% of responsive individuals. The test material must be validated by comparison with a previously validated suspension in patients with and without sarcoidosis.
    119. 119. THE KVEIM-SILTZBACH TEST Because of the difficulties involved in preparation, standardization and validation of the test material as well as significant variation in the sensitivity and specificity of test suspensions obtained from different sources, the need for a biopsy procedure and the wait of 4-6 weeks for a diagnosis, the Kveim test has been largely replaced by transbronchial biopsy for the diagnosis of sarcoidosis. At the present time validated Kveim test suspensions are available for diagnostic use at very few institutions worldwide.
    120. 120. KVEIM TEST - SKIN BIOPSY NON-NECROTIZING GRANULOMAS
    121. 121. KVEIM TEST - SKIN BIOPSY NON-NECROTIZING GRANULOMAS
    122. 122. KVEIM TEST - SKIN BIOPSY NON-NECROTIZING GRANULOMAS
    123. 123. DIAGNOSIS Test not always positive Not used often in US Test material not approved for sale by FDA.
    124. 124. PROGNOSIS Good 50% have some permanent organ dysfunction In 15-20% remains active or recurs intermittently.
    125. 125. THANKYOU

    ×